Nadia Speaks...

Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs

31 min · 8. Juni 2025
Episode Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs Cover

Beschreibung

In this episode, Nadia sits down with her brother, renowned cancer surgeon Dr. Anton Bilchik, to delve into the future of weight loss, metabolism, and significant medical breakthroughs. This episode dives into why obesity, an epidemic and major risk factor for cancer and heart disease, is so difficult to manage through traditional means and how novel GLP-1 and dual agonist drugs are changing the landscape of sustainable weight loss. Dr. Bilchik also shares with us, the latest research into the broader implications of these medications, including their potential for cancer and cardiovascular disease prevention, while emphasizing the critical need for physician oversight and a holistic approach to their use.

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der Nadia Speaks...-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar.

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

23 Folgen

Episode Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs Cover

Nadia Speaks with Dr. Anton Bilchik about the Future of Weight Loss-Medications, Metabolism & Medical Breakthroughs

In this episode, Nadia sits down with her brother, renowned cancer surgeon Dr. Anton Bilchik, to delve into the future of weight loss, metabolism, and significant medical breakthroughs. This episode dives into why obesity, an epidemic and major risk factor for cancer and heart disease, is so difficult to manage through traditional means and how novel GLP-1 and dual agonist drugs are changing the landscape of sustainable weight loss. Dr. Bilchik also shares with us, the latest research into the broader implications of these medications, including their potential for cancer and cardiovascular disease prevention, while emphasizing the critical need for physician oversight and a holistic approach to their use.

8. Juni 202531 min